Not Yet RecruitingNCT06518941
Donepezil and habit-related symptoms in anorexia nervosa
About this title
Read the official source — NCT06518941Medication studyAges 18–60United StatesEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: January 2027
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06518941
- Official title
Show the full official title
An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Donepezil.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
